A New Series of Aryloxyacetic Acids Endowed with Multi-Target Activity towards Peroxisome Proliferator-Activated Receptors (PPARs), Fatty Acid Amide Hydrolase (FAAH), and Acetylcholinesterase (AChE).


Journal

Molecules (Basel, Switzerland)
ISSN: 1420-3049
Titre abrégé: Molecules
Pays: Switzerland
ID NLM: 100964009

Informations de publication

Date de publication:
31 Jan 2022
Historique:
received: 17 12 2021
revised: 20 01 2022
accepted: 27 01 2022
entrez: 15 2 2022
pubmed: 16 2 2022
medline: 24 2 2022
Statut: epublish

Résumé

A new series of aryloxyacetic acids was prepared and tested as peroxisome proliferator-activated receptors (PPARs) agonists and fatty acid amide hydrolase (FAAH) inhibitors. Some compounds exhibited an interesting dual activity that has been recently proposed as a new potential therapeutic strategy for the treatment of Alzheimer's disease (AD). AD is a multifactorial pathology, hence multi-target agents are currently one of the main lines of research for the therapy and prevention of this disease. Given that cholinesterases represent one of the most common targets of recent research, we decided to also evaluate the effects of our compounds on the inhibition of these specific enzymes. Interestingly, two of these compounds,

Identifiants

pubmed: 35164223
pii: molecules27030958
doi: 10.3390/molecules27030958
pmc: PMC8839882
pii:
doi:

Substances chimiques

Cholinesterase Inhibitors 0
Peroxisome Proliferator-Activated Receptors 0
Acetylcholinesterase EC 3.1.1.7
Amidohydrolases EC 3.5.-
fatty-acid amide hydrolase EC 3.5.1.-
Acetic Acid Q40Q9N063P

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Références

J Med Chem. 2007 Feb 22;50(4):685-95
pubmed: 17243659
Nat Commun. 2014 Apr 07;5:3571
pubmed: 24705063
J Med Chem. 2012 Jan 26;55(2):623-38
pubmed: 22148468
Prog Mol Biol Transl Sci. 2014;121:217-66
pubmed: 24373239
J Intern Med. 2018 Dec;284(6):643-663
pubmed: 30051512
Cold Spring Harb Perspect Med. 2012 Jun;2(6):a006262
pubmed: 22675658
Anal Biochem. 1989 Nov 1;182(2):411-8
pubmed: 2610358
J Comput Aided Mol Des. 2019 Dec;33(12):1011-1020
pubmed: 31691919
J Med Chem. 2012 May 10;55(9):4027-61
pubmed: 22260081
Diabetes Care. 2011 Sep;34(9):2008-14
pubmed: 21816979
ACS Chem Neurosci. 2021 Feb 3;12(3):447-461
pubmed: 33428389
Pharmacol Ther. 2013 Apr;138(1):84-102
pubmed: 23333350
Cardiovasc Diabetol. 2013 May 31;12:82
pubmed: 23721199
Curr Opin Investig Drugs. 2010 Jan;11(1):51-62
pubmed: 20047159
Future Med Chem. 2018 Apr 1;10(7):703-705
pubmed: 29671628
Protein Sci. 2009 Apr;18(4):792-800
pubmed: 19309732
Chem Biol Interact. 2019 Aug 25;309:108698
pubmed: 31176713
Nutr J. 2014 Feb 14;13:17
pubmed: 24524207
Alzheimers Res Ther. 2016 Sep 20;8:39
pubmed: 27646601
ChemMedChem. 2017 Aug 22;12(16):1349-1358
pubmed: 28570763
ChemMedChem. 2007 May;2(5):641-54
pubmed: 17357171
Arch Pharm (Weinheim). 2015 Aug;348(8):556-63
pubmed: 26032855
Int J Mol Sci. 2016 Jun 24;17(7):
pubmed: 27347932
Int J Mol Sci. 2021 Jan 20;22(3):
pubmed: 33498245
J Med Chem. 2020 Nov 25;63(22):13291-13315
pubmed: 32805118
J Alzheimers Dis. 2015;43(4):1115-36
pubmed: 25147120
Expert Opin Drug Saf. 2013 Jan;12(1):65-79
pubmed: 23134541
Curr Top Med Chem. 2016;16(17):1889-96
pubmed: 26845553
J Med Chem. 2005 Aug 25;48(17):5509-19
pubmed: 16107150
J Med Chem. 2008 Dec 25;51(24):7768-76
pubmed: 19053776
J Am Chem Soc. 2013 Jan 9;135(1):22-5
pubmed: 23240907
Neural Regen Res. 2020 Jan;15(1):67-68
pubmed: 31535650
Int J Mol Sci. 2018 Jul 27;19(8):
pubmed: 30060458
Life Sci. 2018 Jul 1;204:20-45
pubmed: 29729263
J Med Chem. 2019 Dec 26;62(24):10995-11003
pubmed: 31407888
J Biol Chem. 2014 Mar 7;289(10):6908-6920
pubmed: 24451380
J Med Chem. 2020 Sep 24;63(18):10109-10134
pubmed: 32539376
J Cheminform. 2011 Oct 07;3:33
pubmed: 21982300
ChemMedChem. 2016 Jun 6;11(11):1117-21
pubmed: 27218427
Curr Med Chem. 2015;22(3):373-404
pubmed: 25386820
Alzheimers Res Ther. 2019 Nov 28;11(1):93
pubmed: 31779690
J Med Chem. 2012 Oct 25;55(20):8807-26
pubmed: 23043222
Handb Exp Pharmacol. 2015;231:233-59
pubmed: 26408163
Eur J Pharm Sci. 2017 Nov 15;109:381-388
pubmed: 28801274
J Med Chem. 2018 Sep 27;61(18):8282-8298
pubmed: 30199253
Drug Discov Today. 2018 Aug;23(8):1520-1529
pubmed: 29567427
Behav Brain Res. 2011 Aug 10;221(2):334-40
pubmed: 20060018
Br J Pharmacol. 2016 Jun;173(12):1899-910
pubmed: 27077495
Comput Biol Chem. 2018 Jun;74:304-326
pubmed: 29747032
Int J Mol Sci. 2020 Sep 24;21(19):
pubmed: 32987725
Cells. 2021 Mar 07;10(3):
pubmed: 33799988

Auteurs

Rosalba Leuci (R)

Dipartimento di Farmacia-Scienze del Farmaco, Università degli Studi di Bari "Aldo Moro", Via E. Orabona 4, 70125 Bari, Italy.

Leonardo Brunetti (L)

Dipartimento di Farmacia-Scienze del Farmaco, Università degli Studi di Bari "Aldo Moro", Via E. Orabona 4, 70125 Bari, Italy.

Antonio Laghezza (A)

Dipartimento di Farmacia-Scienze del Farmaco, Università degli Studi di Bari "Aldo Moro", Via E. Orabona 4, 70125 Bari, Italy.

Luca Piemontese (L)

Dipartimento di Farmacia-Scienze del Farmaco, Università degli Studi di Bari "Aldo Moro", Via E. Orabona 4, 70125 Bari, Italy.

Antonio Carrieri (A)

Dipartimento di Farmacia-Scienze del Farmaco, Università degli Studi di Bari "Aldo Moro", Via E. Orabona 4, 70125 Bari, Italy.

Leonardo Pisani (L)

Dipartimento di Farmacia-Scienze del Farmaco, Università degli Studi di Bari "Aldo Moro", Via E. Orabona 4, 70125 Bari, Italy.

Paolo Tortorella (P)

Dipartimento di Farmacia-Scienze del Farmaco, Università degli Studi di Bari "Aldo Moro", Via E. Orabona 4, 70125 Bari, Italy.

Marco Catto (M)

Dipartimento di Farmacia-Scienze del Farmaco, Università degli Studi di Bari "Aldo Moro", Via E. Orabona 4, 70125 Bari, Italy.

Fulvio Loiodice (F)

Dipartimento di Farmacia-Scienze del Farmaco, Università degli Studi di Bari "Aldo Moro", Via E. Orabona 4, 70125 Bari, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH